Stage III: Innovations on the "Big Stage"
The management of stage III NSCLC is controversial and rapidly evolving, to the point that practitioners have difficulty processing and understanding the fast moving changes in the standard of care and communications among multidisciplinary teams is challenging given the uneven knowledge levels.
It is imperative that lung cancer health care professionals remain current in the state-of-the-art management and techniques. Attendees need to determine when and how the latest clinical trial findings will affect their day-to-day practice, and thus be able to narrow competency gaps in management of this large proportion of NSCLC patients.
This will be a series of lectures by experts on complex areas in the current management of stage III NSCLC. Panelists will provide foundational information and then will dialogue as a group under the direction of the moderator to clarify areas of uncertainty and controversy. Panelists will also answer questions from the participants in the audience to further explain difficult clinical challenges in stage III NSCLC.
This meeting is designed to meet the interests of medical oncologists, radiation oncologists, surgeons, physicists, nurses, diagnostic radiologists, pathologists, radiation therapists, radiation dosimetrists and pulmonologists.
Upon completion of this activity, participants should be able to do the following:
- Increase level of knowledge and skills in managing stage III NSCLC.
- When appropriate, apply new strategies and make practice modifications.
- Improve multidisciplinary understanding and communication about stage III NSCLC.
- Sue Yom, MD, PhD, FASTRO
- Linda Martin, MD, MPH
- Salma Jabbour, MD, FASTRO
- Steven Lin
- Carl Gay, MD, PhD
A list of all meeting faculty and Individual presenter disclosures are linked to their names in the Schedule of Events.
A list of all meeting planning committee members and their individual disclosures can be found on the Planning Committee website page.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.50 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.50 Certificate of AttendanceThis activity was designated for 1.50 AMA PRA Category 1 Credit™.